Navigation Links
DrugRisk Announces New Pradaxa Health Warning From Australia
Date:1/5/2013

Orlando, FL (PRWEB) January 05, 2013

The prescription drug resource center DrugRisk.com has added new information to its already comprehensive database for the blood thinner Pradaxa, after an Australian health advisory questioned whether the drug was safe enough for the government to supply it to citizens.

“DrugRisk’s goal is to improve patient safety through education with the latest drug warnings, recalls, studies and litigation news. Although most people never hear about drug warnings from other countries, these can be just as important as those in the U.S.,” explained DrugRisk representative Ryan Mayer.

Last month, Australia’s Pharmaceutical Benefits Advisory Committee (PBAC) warned that they may withdraw recommendations that the government continue to furnish prescriptions of Pradaxa.*

The Committee noted concerns that, while Pradaxa may have health and financial benefits over other anticoagulants, it may be prescribed for patients and at dosages not tested in clinical trials.

In the United States, experts disagree about the safety of Pradaxa bleeding risks. Last month the FDA updated warnings to say the drug carries the same risks as warfarin.** However, the New York Times also reported doctors’ concerns that Pradaxa led all medications for adverse reports and currently has no antidote for internal bleeding.***

Most common among the adverse reports were 6497 gastrointestinal side effects, 4910 gastrointestinal hemorrhages (bleeding) and 2941 central nervous system or cranial hemorrhaging problems. There were also 842 deaths attributed to the drug.****

Since September, the number of patients filing a Pradaxa lawsuit over internal bleeding has risen 50%.***** The cases have now been moved to a special federal court in Illinois, formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.

Anyone affected by internal bleeding after Pradaxa use is urged to speak with a lawyer about their legal options as soon as possible. Due to the specialized nature of federal drug injury cases, the Drug Risk Resource Center only recommends lawyers who are already handling Pradaxa lawsuits.

For more information on the research, side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*pharmatimes.com/Article/12-12-20/Australia_warning_over_Pradaxa_PBS_listing.aspx
**fda.gov/Drugs/DrugSafety/ucm332912.htm***fda.gov/Drugs/DrugSafety/ucm326580.htm
***nytimes.com/2012/11/03/business/a-rising-anti-stroke-drug-is-tied-to-risk-of-bleeding-deaths.html
****adverseevents.com/drugdetail.php?AEDrugID=1067&BrandName=PRADAXA
*****jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets-By-District-November-2012.pdf

Read the full story at http://www.prweb.com/releases/pradaxa-internal/bleedings-risks/prweb10290093.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisk Adds Latest Health Warnings and Lawsuit Updates for Yaz
2. DrugRisk Announces Updated Information on Mirena Lawsuits
3. DrugRisk Announces Alternative to Mirena IUD May Be Available Soon
4. DrugRisk Center Announces Court Postponement of NuvaRing Lawsuits
5. The Life Support Technologies Group Announces 2013 Hyperbaric Medical Training Course Dates
6. Barton Associates Announces OB/GYN Locum Tenens Staffing Group
7. PCH Mutual Insurance CO., A RRG Announces Dividend for 2013
8. CoachingWebsites (Websites for Coaches) Announces a New Scheduling Calendar Feature for Coaches in 2013
9. Footwear etc. Announces the New Spring Collection from Orthaheel
10. Nutrisystem Announces Latest Weight Loss Success Story: Long Beach Husband and Wife Drop a Combined Total of 46 Pounds; Plus, Expert Dieting Tips for Couples
11. PMD Healthcare Announces how Spiro PD Personal Spirometer Supports New Year’s Resolution to Exercise and Lose Weight, Complementing ACAAI Recommendations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... January 20, 2017 , ... Source Vitál Apothecary, a skin and body ... oils, announced the company had a successful visit to the 2017 ECRM Diet, Vitamin ... companies that work in the nutritional, sports and health industries a chance to meet ...
(Date:1/20/2017)... ... January 20, 2017 , ... International Protein, a company based out of Australia ... attended the January ECRM trade show in Hilton Head, SC. , International Protein ... to create a line of products that would elevate her fitness regime. At this ...
(Date:1/20/2017)... ... ... “The Angel”: a heartwarming and earnest tale of faith and believing ... “The Angel” is the creation of published author, Marjorie Lund-Fontaine, a former professional violinist, ... , When asked of her new book, Marjorie says, “‘The Angel’ was written as ...
(Date:1/20/2017)... ... ... “Journey to Christmas:” a beautiful and enchanting tale that teaches children the true meaning of ... three in Oklahoma City, and a devoted woman of faith. , “Becoming a parent ... the back of my mind for years, but actually doing it might have been a ...
(Date:1/19/2017)... , ... January 19, 2017 ... ... the Aerolib Learning Management System: an On-demand E-learning system for Clinical and ... Hospital Administration that is based on Aerolib`s successful education methodology of Disease ...
Breaking Medicine News(10 mins):
(Date:1/20/2017)... , Jan. 20, 2017 Wells Specialty Pharmacy announces ... Howell Branch Rd in Winter Park, Florida ... Park . Operations have been consolidated into the 3796 ... also pleased to announce that Chad Tomlinson , former ... the Company effective immediately. Mr. Tomlinson is a Graduate of ...
(Date:1/20/2017)... 20, 2017 Avillion LLP, a co-developer and ... Mark Weinberg , MD MBA as Chief Medical Officer. Dr Weinberg ... USA . ... Dr Weinberg has spent more than 17 years as a pharmaceutical ... to micro-cap biotech. Over the course of his career, he has ...
(Date:1/19/2017)... Jan. 19, 2017 The global immunomodulators ... by 2025, according to a new study by ... to be predominantly driven by high R&D investments ... large-scale production of new and therapeutically advanced drugs. ... drugs at an unprecedented rate into the immunomodulators ...
Breaking Medicine Technology: